-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Peramivir
Category | Influenza Virus |
CAS | 330600-85-6 |
Description | Peramivir is an antiviral inhibitor with an IC50 of median 0.09 nM. It prevents the virus from infecting cells. |
Product Information
Synonyms | BCX 1812; BCX1812; BCX-1812 (1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic Acid |
IUPAC Name | (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid |
Molecular Weight | 328.41 |
Molecular Formula | C15H28N4O4 |
Canonical SMILES | CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C |
InChI | InChI=1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1 |
InChIKey | RQDFNLINLXZLB-CKIKVBCHSA-N |
Melting Point | 170-172 °C |
Purity | ≥98.0% |
Density | 1.39 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | White to Off-White Solid |
Application | A new antiviral agent for influenza treatment, could be used as neuraminidase inhibitor for treating human and avian influenza. |
Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
Storage | Store at -20 °C |
Complexity | 460 |
Exact Mass | 328.21105539 |
Index Of Refraction | 1.614 |
PSA | 151.03000 |
Target | IC50 values ranging form 0.9 to 4.3 nM for nine influenza virus neuraminidase subtypes. |
XLogP3-AA | 0 |